Expert Opinion on Therapeutic Targets

Tumor necrosis factor as a therapeutic target of rheumatologic disease
pp. 1369-1384(16)
Authors: Ackermann, Christoph; Kavanaugh, Arthur

Targets for regulating angiogenesis in the ageing endothelium
pp. 1385-1399(15)
Authors: Ballard, Victoria LT; Edelberg, Jay M

Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances
pp. 1401-1413(13)
Authors: Wood, Susan K; Woods, James H

Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis
pp. 1415-1428(14)
Authors: Corona, Juan C; Tovar-y-Romo, Luis B; Tapia, Ricardo

Expanding the repertoire of RNA interference screens for developing new anticancer drug targets
pp. 1429-1441(13)
Author: Haney, Steven A

Tumour targeting by microtubule-depolymerising vascular disrupting agents
pp. 1443-1457(15)
Authors: Kanthou, Chryso; Tozer, Gillian M

X-linked inhibitor of apoptosis protein as a therapeutic target
pp. 1459-1471(13)
Authors: Dean, Emma J; Ranson, Malcolm; Blackhall, Fiona; Dive, Caroline

Targeting selectins and selectin ligands in inflammation and cancer
pp. 1473-1491(19)
Authors: Barthel, Steven R; Gavino, Jacyln D; Descheny, Leyla; Dimitroff, Charles J

Targeting the retinal microcirculation to treat diabetic sight problems
pp. 1493-1502(10)
Authors: Schiffelers, Raymond M; Fens, Marcel Ham; van Blijswijk, Janneke M; Bink, Dieuwertje I; Storm, Gert

Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat Type 2 diabetes
pp. 1503-1520(18)
Authors: Pascual, Gabriel; Ricote, Mercedes; Hevener, Andrea L